MB
Healthcare & Life Sciences
March Biosciences
United Statesmarch.bio
March Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
Activeseries-a
series-a
Stage
2
Investors
About March Biosciences
March Biosciences is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
March Biosciences is a clinical-stage cell therapy company developing CAR-T cell therapies targeting hematological cancers, with a lead asset MB-105 focused on treating relapsed/refractory T-cell lymphoma by targeting the CD5 antigen.
Explore March Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.